sellWeak
Bvf Partners L P/il sold $293 of EPIX
owner at ESSA Pharma Inc.. 156 shares at an average of $1.88, traded Aug 5, 2025, filed Aug 7, 2025.
Warning score
12Value
$293
156 shares
Holdings after
560,797
-0% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- 0Trade size$293 at market
- 0Share of holdings soldSold 0.0% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000921895-25-002133, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 5, 2025 | XIn-the-money exercise Common Stock | +1,481,634 | $0.00 | $148 | 6,194,224 | Aug 7, 2025 |
| Aug 5, 2025 | XIn-the-money exercise Common Stock | +1,235,030 | $0.00 | $124 | 4,726,809 | Aug 7, 2025 |
| Aug 5, 2025 | XIn-the-money exercise Common Stock | +203,336 | $0.00 | $20 | 560,808 | Aug 7, 2025 |
| Aug 5, 2025 | SOpen-market sale Common Stock | -79 | $1.88 | $148 | 6,194,145 | Aug 7, 2025 |
| Aug 5, 2025 | SOpen-market sale Common Stock | -66 | $1.88 | $124 | 4,726,743 | Aug 7, 2025 |
| Aug 5, 2025 | SOpen-market sale Common Stock | -11 | $1.88 | $21 | 560,797 | Aug 7, 2025 |
| Aug 5, 2025 | XIn-the-money exercise Pre-funded Warrantsderivative | -1,481,634 | $0.00 | $0 | 0 | Aug 7, 2025 |
| Aug 5, 2025 | XIn-the-money exercise Pre-funded Warrantsderivative | -1,235,030 | $0.00 | $0 | 0 | Aug 7, 2025 |
| Aug 5, 2025 | XIn-the-money exercise Pre-funded Warrantsderivative | -203,336 | $0.00 | $0 | 0 | Aug 7, 2025 |
Related signals
Other insiders at ESSA Pharma Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | EPIXsell ESSA Pharma Inc. | Biotech Growth N V owner | $12M 7,879,583 shares | -100% | |
| 31Weak | EPIXbuy ESSA Pharma Inc. | Franklin M Berger director | $133k 23,259 shares | +3% | |
| 34Weak | EPIXbuy ESSA Pharma Inc. | Franklin M Berger director | $420k 76,471 shares | +11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.